Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

NCT04544098 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors
Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors

Interventions

DRUG: 177Lu-DOTATATE

Sponsor

Memorial Sloan Kettering Cancer Center